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Summary. Nitric oxide (NO) is a widely recognized 
mediator of physiological and pathophysiological signal 
transmission. Its generation through L-arginine 
metabolism is relevant in the mesangium of the kidney 
where NO is produced by constitutive and inducible NO- 
synthase isoenzymes. Signaling is achieved through 
target interactions via redox and additive chemistry. In 
mesangial cells (MC), the outcome of these 
modifications promote on one side activation of soluble 
guanylyl cyclase while on the other side cytotoxicity is 
elicited. These contrasting situations are characterized 
by: 1) cGMP formation and signal propagation towards 
myosin light chain kinase, the effector system that 
regulates F-actin assembly, thereby affecting reversible 
relaxation/contraction of mesangial cells;  and 2) 
initiation of morphological and biochemical alterations 
that are reminiscent of apoptosis such as chromatin 
condensation, p53 or Bax accumulation as well as 
caspase-3 activation. Off note, NO formation with 
concomitant initiation of apoptosis is efficiently 
antagonized by the simultaneous presence of superoxide 
(02-). We will recall the consequences that stem from a 
diffusion controlled NO/02-  interaction thereby 
redirecting the apoptotic initiating activity of either NO 
or 02 -  towards protection. The crosstalk between cell 
destructive and protective signaling pathways, their 
activation or inhibition under the modulatory influence 
of NO will be discussed. Here we give examples of how 
NO elicits physiological and pathophysiological signal 
transmission in rat MC. 
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Nitric oxide: Endogenous formation and NO donors 
In the late 1980s it was discovered that nitric oxide 
(NO) participates in regulating vascular, immune, and 
neurological responses. This motivated intense searches 
for NO biosynthesis and actions throughout the body. 
NO is enzymatically produced by NO-synthase (NOS) 
isoforms in a reaction scheme, involving the five 
electron oxidation of the terminal guanido nitrogen of 
the amino acid L-arginine to form NO and 
stoichiometric amounts of citrulline (Mayer and 
Hemmens, 1997). The initial NOS nomenclature 
reflected the early observations that NO synthesis was 
characteristic upon immunoactivation of inflammatory 
cel ls  (Moncada et al., 1991;  Nathan, 1992). The  
corresponding enzyme therefore was designated 
"inducible NOS" (iNOS, also known as NOS2). The 
iNOS was contrasted to a constitutive NOS activity, 
"cNOS", that was expressed in characteristic cell types 
(neuronal cells or endothelial cells, with enzymes known 
as nNOS or NOS1 and eNOS or NOS3). It is now 
realized that the level of gene expression of cNOS 
isoforms may be induced and conversely, that iNOS may 
function as a "constitutive" enzyme. However, a widely 
accepted nomenclature describes isoformes as nNOS, 
iNOS, and eNOS, reflecting the tissue for the original 
protein and cDNA isolates (Michel and Feron, 1997). 
Once activated, NOS isoforms not only produce NO, the 
primary reaction product, but also those species resulting 
from oxidation, reduction, or adduction of NO in 
physiological milieus, thereby producing various 
nitrogen oxides, S-nitrosothiols, peroxynitrite (ON00-), 
and transition metal adducts (Stamler et al., 1992). 
Classification of isoenzyme activity allows to 
approximate a low versus high output system for 
endogenously generated NO and a rough correspondence 
between toxic and homeostatic functions of the 
molecule. NOS inhibitors such as ~ ~ - m o n o r n e t h ~ l - ~ -  
arginine (NMMA) or other derivatives of the natural 
substrate L-arginine are commonly used to intervene 
pharmacologically in NO production, thus allowing to 

















